Ultragenyx Stock Options

RARE Stock  USD 42.66  1.16  2.80%   
Ultragenyx's latest option contracts expiring on January 17th 2025 are carrying combined implied volatility of 0.61. The Ultragenyx option chain provides detailed quote and price information for the current Ultragenyx option contracts. It shows all of Ultragenyx's listed puts, calls, expiration dates, strike prices, and other pricing information.

Ultragenyx Maximum Pain Price Across 2025-01-17 Option Contracts

Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Ultragenyx close to expiration to expire worthless. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, Ultragenyx's option sellers may reap the most after selling more options than buying, causing them to expire worthless.

In The Money vs. Out of Money Option Contracts on Ultragenyx

Analyzing Ultragenyx's in-the-money options over time can help investors to take a profitable long position in Ultragenyx regardless of its overall volatility. This is especially true when Ultragenyx's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Ultragenyx's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Ultragenyx's stock while costing only a fraction of its price.
Ultragenyx's stock options are financial instruments that give investors the right to buy or sell shares of Ultragenyx common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Ultragenyx stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Ultragenyx's stock price goes up or down, the stock options follow.
At present, Ultragenyx's Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 4.4 B, whereas Common Stock Shares Outstanding is forecasted to decline to about 50.9 M.

Ultragenyx Current Options Market Mood

Ultragenyx's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Ultragenyx Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Volume

Unfortunately, most Ultragenyx's options investors are not very successful. Ultragenyx's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Ultragenyx contract

Base on the Rule 16, the options market is currently suggesting that Ultragenyx will have an average daily up or down price movement of about 0.0381% per day over the life of the 2025-01-17 option contract. With Ultragenyx trading at USD 42.66, that is roughly USD 0.0163. If you think that the market is fully incorporating Ultragenyx's daily price movement you should consider buying Ultragenyx options at the current volatility level of 0.61%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing Ultragenyx options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Ultragenyx calls. Remember, the seller must deliver Ultragenyx stock to the call owner when a call is exercised.

Ultragenyx Option Chain

When Ultragenyx's strike price is surpassing the current stock price, the option contract against Ultragenyx stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Ultragenyx's option chain is a display of a range of information that helps investors for ways to trade options on Ultragenyx. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Ultragenyx. It also shows strike prices and maturity days for a Ultragenyx against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
RARE250117C00025000025.023.6 - 28.023.6Out
Call
RARE250117C00030000030.020.3 - 24.520.3Out
Call
RARE250117C00035000035.016.5 - 21.016.5Out
Call
RARE250117C00040000040.013.4 - 17.513.4Out
Call
RARE250117C00045000045.010.6 - 14.910.6Out
Call
RARE250117C00050000050.09.0 - 13.09.0Out
Call
RARE250117C00055000055.07.2 - 10.87.2Out
Call
RARE250117C00060000060.05.4 - 8.25.4Out
Call
RARE250117C00065000065.04.4 - 7.74.4Out
Call
RARE250117C00070000070.02.95 - 5.92.95Out
 Put
RARE250117P00025000025.00.5 - 3.10.5Out
 Put
RARE250117P00030000030.01.4 - 4.41.4Out
 Put
RARE250117P00035000035.02.7 - 5.92.7Out
 Put
RARE250117P00040000040.03.3 - 7.83.3Out
 Put
RARE250117P00045000045.06.1 - 9.76.1Out
 Put
RARE250117P00050000050.09.7 - 11.79.7Out
 Put
RARE250117P00055000055.012.6 - 15.412.6Out
 Put
RARE250117P00060000060.014.5 - 18.314.5Out
 Put
RARE250117P00065000065.018.7 - 21.918.7Out
 Put
RARE250117P00070000070.022.4 - 26.322.4Out

Ultragenyx Market Cap Over Time

   Market Cap   
       Timeline  

Ultragenyx Total Stockholder Equity

Total Stockholder Equity

481.13 Million

At present, Ultragenyx's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting.

Ultragenyx Corporate Management

Dennis HuangChief Technical Operations Officer and Sr. VPProfile
Theodore HuizengaCorporate VPProfile
Arjun NatesanVice ResearchProfile
Vimal SrivastavaSenior ManagementProfile
Aaron OlsenSenior FinanceProfile
Paul JDVice PropertyProfile
When determining whether Ultragenyx is a strong investment it is important to analyze Ultragenyx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ultragenyx's future performance. For an informed investment choice regarding Ultragenyx Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ultragenyx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ultragenyx. If investors know Ultragenyx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ultragenyx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(6.35)
Revenue Per Share
6.015
Quarterly Revenue Growth
0.423
Return On Assets
(0.24)
Return On Equity
(2.90)
The market value of Ultragenyx is measured differently than its book value, which is the value of Ultragenyx that is recorded on the company's balance sheet. Investors also form their own opinion of Ultragenyx's value that differs from its market value or its book value, called intrinsic value, which is Ultragenyx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ultragenyx's market value can be influenced by many factors that don't directly affect Ultragenyx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ultragenyx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ultragenyx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ultragenyx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.